• No image available for this medication
    • DARZALEX FASPRO

    • QTY 15
    • 1800-30000
    • VIAL

DARATUMUMAB; HYALURONIDASE (dar a toom ue mab / hye al ur ON i dase) is a monoclonal antibody. Hyaluronidase is used to improve the effects of daratumumab. It treats certain types of cancer. Some of the cancers treated are multiple myeloma and light-chain amyloidosis.


DARZALEX FASPRO Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.